Vote!

Pfizer, Astellas prostrate cancer drug clears late-stage trial

Sept 14 (Reuters) - Pfizer Inc and Astellas Pharma Inc said on Thursday their drug to treat a type of prostrate cancer met the main goal of improving overall survival in a late-stage trial. ...

read more...

Share |

Published By: Reuters (Company news) - Thursday, 14 September